Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field

Details for Australian Patent Application No. 2011219933 (hide)

Owner Formevet s.r.l.

Inventors Formenti, Andrea; Formenti, Filippo

Agent Golja Haines & Friend

Pub. Number AU-A-2011219933

PCT Pub. Number WO2011/104161

Priority MI2010A000318 26.02.10 IT

Filing date 17 February 2011

Wipo publication date 1 September 2011

International Classifications

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/341 - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 29/02 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/104161 Priority application(s): WO2011/104161

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219941-Compositions for targeted delivery of siRNA

2011219927-Plants having enhanced yield-related traits and a method for making the same